Total revenues of $22.4 million for the fiscal year 2016 compared to $23.5 million for the fiscal year 2015

For the fiscal year 2016 net income attributable to SWK Stockholders of $28.9 million, or $2.22 per share, and non-GAAP adjusted net income attributable to SWK Stockholders of $6.7 million, or $0.51 per share

Deferred tax asset increased to $38.5 million at December 31, 2016 from $16.8 million at December 31, 2015

Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entity less non-controlling interests) were $132.2 million as of December 31, 2016, a 22.1% increase from December 31, 2015

Book value of $15.68 per share as of December 31, 2016 vs. $13.47 as of December 31, 2015

$32.2 million of cash available for deployment as of December 31, 2016

For the full year 2016, closed seven new financings deploying $67.8 million at a weighted average 17.6% GAAP projected effective yield

For the full year 2016, three SWK financing partners were acquired by strategic buyers

Dallas, TX, March 17, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year 2016 financial results.

Total revenues of $4.2 million for the third quarter of 2016 compared to $5.7 million for the third quarter of 2015

For the third quarter of 2016 net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP adjusted net income of $2.6 million, or $0.20 per share

For the first-nine months of 2016 net income attributable to SWK Shareholders of $5.2 million, or $0.39 per share, and non-GAAP adjusted net income of $4.2 million, or $0.32 per share

Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entities less non-controlling interests) were $95.3 million as of September 30, 2016

Book value of $13.74 per share as of September 30, 2016

$66.4 million of cash available for deployment

YTD through November 8, closed four new financings deploying $31.4 million at a weighted average 15.5% GAAP projected effective yield

After quarter close, one SWK partner signed agreement to be acquired; YTD three SWK partners have been acquired by strategic buyers

Total revenues of $8.6 million for the three months ended June 2016 compared to $5.4 million for the second quarter of 2015

For the three months ended June 2016 net loss attributable to SWK Shareholders of $1.0 million, or $0.08 per share, and non-GAAP adjusted net loss of $0.6 million, or $0.04 per share

For the six months ended June 2016 net income attributable to SWK Shareholders of $2.1 million, or $0.16 per share, and non-GAAP adjusted net income of $2.5 million, or $0.19 per share

Total income producing assets (defined as finance receivables, marketable securities and investment in unconsolidated subsidiaries less non-controlling interests) were $81.9 million as of June 30, 2016

Book value of $13.62 per share as of June 30, 2016

$76.6 million of cash available for deployment

YTD through August 10, closed four new financings deploying $32.0 million at a weighted average 15.5% GAAP projected effective yield

For the three months ended June 2016 two SWK partners were acquired by strategic buyers; YTD three SWK partners have been acquired by strategic buyers

Total revenues increased by 35% to approximately $23.5 million for the fiscal year of 2015, compared to $17.4 million for the fiscal year of 2014

Recorded a net loss attributable to SWK stockholders of $7.4 million, or $(0.57) per share, for the fiscal year of 2015, compared to net income attributable to SWK stockholders of $20.8 million, or $3.20 per share, for the fiscal year of 2014

Net cash provided by operating activities increased by 119% to approximately $11.2 million, or $0.86 per share, for the fiscal year of 2015, compared to $5.1 million, or $0.79 per share, for the fiscal year of 2014

Recorded aggregate provisions for loan credit loss and security impairment expense of $17.5 million related primarily to SynCardia Systems and Response Genetics positions

Non-GAAP Adjusted net loss of $1.4 million, or $(0.11) per share, for the fiscal year of 2015, compared Non-GAAP Adjusted net income of $10.7 million, or $1.65 per share, for the fiscal year of 2014

Book value of $13.47 per share as of December 31, 2015

Dallas, TX, March 23, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced today its fourth quarter and full year 2015 financial results.

Total revenues increased by 53% to approximately $5.7 million for the third quarter of 2015, compared to $3.7 million for the third quarter of 2014

Recorded a net loss attributable to SWK stockholders of $5.8 million, or ($0.44) per share for the third quarter of 2015, compared to net income attributable to SWK stockholders of $0.4 million, or $0.06 per share for the third quarter of 2014

Recorded $8.1 million provision for credit losses related to Response Genetics and SynCardia Systems term loans

Non-GAAP Adjusted net loss of $6.9 million, or ($0.53) per share, for the third quarter of 2015, compared Non-GAAP Adjusted net income of $1.5 million, or $0.22 per share, for the third quarter of 2014

Executed a 1-for-100 reverse stock split of the common stock, followed by a 10-for-1 forward stock split of the common stock

Dallas, TX –– 9/16/15 – SWK Holdings Corporation (OTCQB: SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, announced a clarification on the timing of the trading of the Company’s common stock on a post-split basis following the execution of the previously announced stock splits effective as of 5:00 p.m. on September 15, 2015.

Dallas, TX – 08/28/15 – SWK Holdings Corporation (OTCQB: SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, today announced a 1-for-100 reverse stock split of its common stock, immediately followed by a 10-for-1 forward stock split of its common stock. The stock splits will be effective as of 5:00 pm Eastern Time September 15, 2015. Beginning with the opening of trading on September 16, 2015, the Company’s common stock will trade on OTCQB on a post-split basis. The stock split was approved at SWK’s 2015 Annual Meeting of Stockholders held on May 20, 2015.